Livagen
Hepatic support research, Gene-expression and chromatin studies, Cellular aging models, Liver resilience
Half-Life
Not Well Characterized
Administration
Injection
Frequency
Daily
How it works
- Hepatic support research
- Gene-expression and chromatin studies
- Cellular aging models
- Liver resilience
Dosing structure
Lower range
10–15 mg
Higher range
10–15 mg
Frequency
Daily
Notes
Typically Administered As Defined Courses (10–20 Days) Repeated 1–2x Per Year
Example protocols
Example A
Dose: 10–15 mg
Frequency: Daily
Duration: 10-30 days
Off period: Not listed
Example B
Dose: 10–15 mg
Frequency: Daily
Duration: 10-30 days
Off period: Not listed
Protocol Notes
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.